NCT06272253 - UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

March 19, 2024

Study Completion Date

July 19, 2024

Conditions

COVID-19 PandemicCOVID-19 Vaccines

Interventions

BIOLOGICAL

INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg

Dose : 1 dose 0.5 ml containing 5 μg inactivated SARS-CoV-2 virus, Tween 80, histidine, Polysorbate 80, Aluminium hydroxide gel, and sodium chloride.

Trial Locations (1)

Dr. Soetomo General Hospital, Surabaya